First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors
{{output}}
Background: Pulmonary lymphoepithelial carcinoma (PLEC) is a rare malignancy with limited evidence for unresectable disease. We compared platinum-based doublet chemotherapy with or without programmed cell death 1 (PD-1) inhibitio... ...
